###begin article-title 0
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 70 76 <span type="species:ncbi:13443">Coffee</span>
Catechol-O-Methyltransferase Gene Polymorphism Modifies the Effect of Coffee Intake on Incidence of Acute Coronary Events
###end article-title 0
###begin p 1
Conceived and designed the experiments: SV PH JS PH. Performed the experiments: PH JS PH. Analyzed the data: SV TT PH JS PH. Contributed reagents/materials/analysis tools: JS. Wrote the paper: SV TT PH JS PH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 312 313 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 12 18 <span type="species:ncbi:13443">coffee</span>
###xml 151 157 <span type="species:ncbi:13443">coffee</span>
The role of coffee intake as a risk factor for coronary heart disease (CHD) has been debated for decades. We examined whether the relationship between coffee intake and incidence of CHD events is dependent on the metabolism of circulating catecholamines, as determined by functional polymorphism of the catechol-O-methyltransferase (COMT) gene.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 19 22 <span type="species:ncbi:9606">men</span>
###xml 106 118 <span type="species:ncbi:9606">participants</span>
###xml 413 419 <span type="species:ncbi:13443">coffee</span>
###xml 600 606 <span type="species:ncbi:13443">coffee</span>
In a cohort of 773 men who were 42 to 60 years old and free of symptomatic CHD at baseline in 1984-89, 78 participants experienced an acute coronary event during an average follow-up of 13 years. In logistic regression adjusting for age, smoking, family history of CHD, vitamin C deficiency, blood pressure, plasma cholesterol concentration, and diabetes, the odds ratio (90% confidence interval) comparing heavy coffee drinkers with the low activity COMT genotype with those with the high activity or heterozygotic genotypes was 3.2 (1.2-8.4). Urinary adrenaline excretion increased with increasing coffee intake, being over two-fold in heavy drinkers compared with nondrinkers (p = 0.008 for trend).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 6 12 <span type="species:ncbi:13443">coffee</span>
###xml 77 80 <span type="species:ncbi:9606">men</span>
###xml 236 242 <span type="species:ncbi:13443">coffee</span>
Heavy coffee consumption increases the incidence of acute coronary events in men with low but not high COMT activity. Further studies are required to determine to which extent circulating catecholamines mediate the relationship between coffee intake and CHD.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Greenland1">[1]</xref>
###xml 124 127 124 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Gyntelberg1">[2]</xref>
###xml 306 309 306 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Nawrot1">[3]</xref>
###xml 600 603 600 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Boekschoten1">[4]</xref>
###xml 674 677 674 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Svilaas1">[5]</xref>
###xml 780 783 780 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Corti1">[6]</xref>
###xml 75 81 <span type="species:ncbi:13443">coffee</span>
###xml 129 135 <span type="species:ncbi:13443">Coffee</span>
###xml 199 205 <span type="species:ncbi:13443">coffee</span>
###xml 368 374 <span type="species:ncbi:13443">coffee</span>
###xml 413 419 <span type="species:ncbi:13443">coffee</span>
###xml 643 649 <span type="species:ncbi:13443">coffee</span>
###xml 702 708 <span type="species:ncbi:13443">coffee</span>
Despite decades of research, controversy persists regarding the effects of coffee consumption on cardiovascular health [1], [2]. Coffee drinking is a prevalent habit worldwide and one constituent of coffee, caffeine, is probably the most frequently ingested pharmacologically active substance in the world [3]. Many of the known or suspected cardiovascular effects of coffee have been attributed to caffeine, but coffee is a mixture of hundreds of chemical substances, many of which have been shown to be pharmacologically active. For example, cafestol increases serum LDL cholesterol concentrations [4], caffeic acid and other polyphenols in coffee are potent antioxidants [5], and even decaffeinated coffee acutely increases blood pressure and muscle sympathetic nerve activity [6].
###end p 9
###begin p 10
###xml 148 151 148 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Happonen1">[7]</xref>
###xml 221 224 221 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Woodward1">[8]</xref>
###xml 226 229 226 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Panagiotakos1">[9]</xref>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Robertson1">[10]</xref>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Robertson2">[11]</xref>
###xml 802 806 802 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Lane1">[12]</xref>
###xml 866 870 866 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Whitsett1">[13]</xref>
###xml 872 876 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Pincomb1">[14]</xref>
###xml 102 108 <span type="species:ncbi:13443">coffee</span>
###xml 379 385 <span type="species:ncbi:13443">coffee</span>
We have recently reported a U-shaped dose-response relationship between intake of caffeine-containing coffee and incidence of acute coronary events [7]; similar findings have been reported from at least two other studies [8], [9]. In order to gain further insight into the pathogenetic mechanisms, we hypothesized that the increased risk in heavy drinkers of caffeine-containing coffee is, at least partly, mediated by increased circulating catecholamine activity. Caffeine is a potent stimulator of plasma renin activity and adrenomedullary secretion; acute ingestion results in substantial increases in plasma concentrations of adrenaline and noradrenaline [10]. Tolerance to these acute humoral effects may develop in the course of one to four days of habitual consumption [11], but is not complete [12] and may be lost after abstinence for as little as 12 hours [13], [14].
###end p 10
###begin p 11
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 273 279 <span type="species:ncbi:13443">coffee</span>
###xml 360 363 <span type="species:ncbi:9606">men</span>
To test this hypothesis, we examined whether the functional polymorphism of the catechol-O-methyltransferase (COMT) gene, resulting in several-fold differences in the metabolism of circulating catecholamines, modifies the effect of heavy consumption of caffeine-containing coffee on the risk of acute coronary events in a cohort of middle-aged eastern Finnish men initially free from symptomatic CHD.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Study design and population
###end title 13
###begin p 14
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Salonen1">[15]</xref>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Salonen2">[16]</xref>
###xml 111 114 <span type="species:ncbi:9606">men</span>
###xml 283 295 <span type="species:ncbi:9606">participants</span>
###xml 437 440 <span type="species:ncbi:9606">men</span>
###xml 496 499 <span type="species:ncbi:9606">men</span>
###xml 565 571 <span type="species:ncbi:13443">coffee</span>
###xml 669 672 <span type="species:ncbi:9606">men</span>
The Kuopio Ischaemic Heart Disease Risk Factor Study is a population-based prospective follow-up study of 2682 men aged 42, 48, 54, or 60 years at the baseline examination carried out in 1984-89 [15]. The study was approved by the University of Kuopio Research Ethics Committee; all participants gave written informed consent. The study population was recruited in two cohorts. The present analysis is based on the latter cohort of 1516 men enrolled between 1986 and 1989. After exclusion of 353 men with prevalent CHD at baseline, as defined earlier [16], data on coffee consumption and smoking, as well as a deoxyribonucleic acid (DNA) sample, were available for 773 men.
###end p 14
###begin title 15
DNA Extraction and COMT Genotyping
###end title 15
###begin p 16
###xml 326 328 326 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LL</italic>
###xml 396 398 396 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HH</italic>
###xml 447 449 447 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LH</italic>
COMT polymorphism is generated by the presence of guanine or adenine at nucleotide 475 encoding a valine or methionine at codon 158 and is recognized by the heat-shock protein 92 II restriction endonuclease. The polymorphism results in three different genotypes: homozygous for the low activity allele (methionine/methionine; LL genotype), homozygous for the high activity allele (valine/valine; HH genotype), and heterozygous (methionine/valine; LH genotype).
###end p 16
###begin p 17
DNA was extracted from 10 mL of ethylenediaminetetraacetic-acid-anticoagulated venous blood using standard salting-out or phenol-chloroform assays. COMT genotypes were determined by restriction fragment length polymorphism analysis from the DNA by an investigator unaware of the phenotype. A 179 base-pair polymerase chain reaction product was generated using the forward 5'-CTG CTG GAG CTG GGG GCC GAC-3' and reverse 5'-AGG TCT TCA GGA ATG C-3' primers. The polymerase chain reaction product (5 microL) was treated with two units of heat-shock protein 92 II for 16 hours at 37degreesC and then analyzed by 2% agarose gel electrophoresis. The diagnostic bands were 179 (valine) and 139 (methionine).
###end p 17
###begin title 18
###xml 14 20 <span type="species:ncbi:13443">Coffee</span>
Assessment of Coffee Intake and Diet
###end title 18
###begin p 19
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Ihanainen1">[17]</xref>
###xml 151 157 <span type="species:ncbi:13443">coffee</span>
###xml 214 225 <span type="species:ncbi:9606">participant</span>
Consumption of foods and beverages was assessed with an instructed and interview-checked 4-day food recording by household measures, including cups of coffee and tea [17]. The volume of the cup mainly used by each participant was estimated by showing photographs of four different cup sizes generally available. Dietary intake of foods and nutrients was calculated using NUTRICA software (National Public Health Institute, Turku, Finland).
###end p 19
###begin title 20
Measurement of Covariates and Catecholamine Excretion
###end title 20
###begin p 21
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Salonen1">[15]</xref>
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Salonen2">[16]</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Salonen2">[16]</xref>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Lakka1">[18]</xref>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Lakka2">[19]</xref>
###xml 682 686 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Nyyssnen1">[20]</xref>
###xml 96 107 <span type="species:ncbi:9606">participant</span>
The examination protocol and measurements have been described previously [15], [16]. Briefly, a participant was defined a current smoker, if he had ever smoked on a regular basis and had smoked within the past 30 days. The lifelong exposure to smoking was estimated as the product of years smoked and the number of cigarettes, cigars, and pipefuls smoked at the baseline examination. Diabetes was defined as self-reported diabetes mellitus or fasting blood glucose of 6.1 mM or more. Assessment of alcohol consumption, serum lipids, blood pressure, and body mass index [16], conditioning leisure-time physical activity [18], waist-hip ratio [19], and plasma vitamin C concentration [20] was carried out as described previously.
###end p 21
###begin p 22
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Salonen3">[21]</xref>
Urinary adrenaline and noradrenaline were purified with commercial phenylboronic acid columns and analyzed under isocratic conditions by reverse-phase liquid chromatography (for a detailed description, see [21]).
###end p 22
###begin title 23
Ascertainment of CHD Events
###end title 23
###begin p 24
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Salonen2">[16]</xref>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Tuomilehto1">[22]</xref>
###xml 510 521 <span type="species:ncbi:9606">participant</span>
The collection of data on and classification of possible acute myocardial infarction and coronary death (here referred to as "acute coronary events") until the end of 1992 is previously described [16], [22]. From 1993, data on acute coronary events were obtained by computer linkage to the national hospital discharge registry; diagnostic information was collected from the hospitals and classified using identical diagnostic criteria. There were no losses to follow-up. In case of multiple events in the same participant, the first event was considered the endpoint.
###end p 24
###begin title 25
Statistical Analysis
###end title 25
###begin p 26
###xml 631 633 631 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LH</italic>
###xml 638 640 638 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LL</italic>
###xml 917 919 917 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HH</italic>
###xml 923 925 923 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LH</italic>
###xml 91 97 <span type="species:ncbi:13443">coffee</span>
###xml 271 277 <span type="species:ncbi:13443">coffee</span>
###xml 350 356 <span type="species:ncbi:13443">coffee</span>
###xml 692 698 <span type="species:ncbi:13443">coffee</span>
###xml 824 830 <span type="species:ncbi:13443">coffee</span>
###xml 885 891 <span type="species:ncbi:13443">coffee</span>
All analyses were performed with SPSS version 11.5 (SPSS Inc., Chicago, IL). Average daily coffee intake was divided into four categories: 0 (non-drinkers), 1 to 375 mL (light drinkers), 376 to 813 mL (moderate drinkers), and 814 mL and over (heavy drinkers). (Since the coffee content in the most common cup size in this population is 125 mL, these coffee intake categories approximately correspond to less than 3 cups, 3 to 6.5 cups, and more than 6.5 cups per day, respectively.) To evaluate biologic interaction (departures from additivity), a single composite variable with six joint-exposure categories was created; the COMT LH and LL genotypes were combined into a single category and coffee non-drinkers were combined with light drinkers. Logistic regression was used to assess the association between the composite coffee intake-COMT variable and acute coronary events; heavy coffee drinkers with either the HH or LH genotype were used as the reference category. Continuous covariates without a meaningful zero value were centered around their respective means. Statistical inference was based on 90% Wald confidence intervals or two-sided p-values.
###end p 26
###begin p 27
###xml 21 33 <span type="species:ncbi:9606">participants</span>
###xml 197 203 <span type="species:ncbi:13443">coffee</span>
In a subgroup of 258 participants with urinary catecholamine measurements, we performed a supplemental linear regression analysis of urinary adrenaline and noradrenaline excretion in categories of coffee intake. Data on catecholamine excretion according to COMT genotype were not available.
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 65 72 65 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000117-t001">Table 1</xref>
###xml 107 114 107 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000117-t002">Table 2</xref>
###xml 685 687 685 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HH</italic>
###xml 878 880 878 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LL</italic>
###xml 38 44 <span type="species:ncbi:13443">coffee</span>
###xml 169 175 <span type="species:ncbi:13443">coffee</span>
###xml 391 397 <span type="species:ncbi:13443">coffee</span>
###xml 658 670 <span type="species:ncbi:9606">Participants</span>
Baseline characteristics according to coffee intake are shown in Table 1 and according to COMT genotype in Table 2. In comparison with light to moderate drinkers, heavy coffee drinkers were more likely to be smokers, had a higher energy and saturated fat intake but lower leisure-time physical activity level, and their LDL cholesterol concentrations were higher. Compared with nondrinkers, coffee drinkers were more likely to be smokers and to have a family history of CHD; had lower leisure-time physical activity levels, a higher body mass index and waist-hip ratio, higher systolic and diastolic blood pressure; and higher LDL cholesterol concentration. Participants with the COMT HH genotype were less likely to be diabetic and had lower levels of leisure-time physical activity than those with the other two genotypes; systolic blood pressure was marginally higher in the LL genotype.
###end p 29
###begin p 30
###xml 74 86 <span type="species:ncbi:9606">participants</span>
###xml 153 159 <span type="species:ncbi:13443">coffee</span>
In the supplemental analysis of urinary catecholamine excretion among 258 participants, the amount of adrenaline excreted was over two-fold in the heavy coffee intake category compared with non-drinkers (p = 0.008 for trend); for noradrenaline, the respective difference was 30% (p = 0.039 for trend).
###end p 30
###begin p 31
###xml 249 251 249 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LL</italic>
###xml 262 269 262 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000117-t003">Table 3</xref>
###xml 442 444 442 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LL</italic>
###xml 710 712 710 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HH</italic>
###xml 716 718 716 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LH</italic>
###xml 888 890 888 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LL</italic>
###xml 990 992 990 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HH</italic>
###xml 996 998 996 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LH</italic>
###xml 1035 1043 1035 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000117-g001">Figure 1</xref>
###xml 146 152 <span type="species:ncbi:13443">coffee</span>
###xml 777 783 <span type="species:ncbi:13443">coffee</span>
A total of 78 acute coronary events were identified during an average follow-up of 13 years. The cumulative incidence rate in other categories of coffee intake was relatively stable (around 10%) but clearly increased in heavy drinkers with the COMT LL genotype (Table 3). After adjustment for age, packyears of smoking, family history of CHD, and vitamin C deficiency, the odds ratio (90% confidence interval) comparing heavy drinkers in the LL genotype with heavy drinkers in the other two genotypes was 3.25 (1.29-8.16). Further adjustment for systolic blood pressure, serum LDL and HDL cholesterol concentration, and diabetes minimally decreased the odds ratio estimate to 3.21 (1.22-8.42). In the combined HH or LH category, the adjusted odds ratios for light and moderate coffee drinkers were 1.45 (0.64-3.27) and 1.39 (0.67-2.88), respectively; the corresponding odds ratios in the LL genotype were 1.73 (0.68-4.42) and 1.31 (0.58-2.99), using the heavy drinkers with either the COMT HH or LH genotype as the reference category (Figure 1). Adjustment for physical activity; intake of alcohol, saturated fat, or total energy; or body mass index and waist-hip ratio did not change the odds ratio estimates appreciably or contribute to model fit.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 47 50 <span type="species:ncbi:9606">men</span>
###xml 194 200 <span type="species:ncbi:13443">coffee</span>
###xml 297 300 <span type="species:ncbi:9606">men</span>
###xml 386 392 <span type="species:ncbi:13443">coffee</span>
###xml 460 463 <span type="species:ncbi:9606">men</span>
###xml 533 539 <span type="species:ncbi:13443">coffee</span>
###xml 749 755 <span type="species:ncbi:13443">coffee</span>
In this population-based cohort of middle-aged men initially free from symptomatic CHD followed-up for an average of 13 years, we found a relationship between consumption of caffeine-containing coffee and the incidence of fatal or nonfatal CHD events that is highly dependent on COMT genotype. In men who were either homozygous for the high COMT activity allele or heterozygotes, heavy coffee intake did not increase the incidence of acute coronary events. In men who were homozygous for the low-activity COMT allele, however, heavy coffee intake was associated with a considerably higher incidence of acute coronary events. The relative excess in CHD incidence in the low-activity genotype was over two-fold among drinkers of more than 6.5 cups of coffee per day, after adjustment for age, smoking, family history of CHD, plasma vitamin C concentration, systolic blood pressure, serum LDL and HDL cholesterol concentration, and diabetes.
###end p 33
###begin p 34
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Wilson1">[23]</xref>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Willett1">[25]</xref>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Rosenberg1">[26]</xref>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-LaCroix1">[27]</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Rosenberg1">[26]</xref>
###xml 85 91 <span type="species:ncbi:13443">coffee</span>
###xml 182 188 <span type="species:ncbi:13443">coffee</span>
###xml 404 410 <span type="species:ncbi:13443">coffee</span>
###xml 539 542 <span type="species:ncbi:9606">men</span>
###xml 562 568 <span type="species:ncbi:13443">coffee</span>
We are not aware of any previous studies that have addressed the modification of the coffee-CHD relationship by COMT activity. Tens of studies investigating the relationship between coffee consumption and the incidence of CHD have been carried out, but the results remain inconsistent. Several large studies carried out in the United States have found no appreciable increase in CHD risk with increasing coffee consumption [23]-[25]. Two earlier U.S. studies, however, reported a two-fold risk of myocardial infarction [26] or CHD [27] in men drinking 5 cups of coffee or more; the risk was three-fold among those drinking 10 cups or more [26], compared with non-drinkers.
###end p 34
###begin p 35
###xml 152 155 152 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Greenland1">[1]</xref>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Kleemola1">[28]</xref>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Hammar1">[30]</xref>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-LaCroix1">[27]</xref>
###xml 354 360 <span type="species:ncbi:13443">coffee</span>
###xml 577 583 <span type="species:ncbi:13443">coffee</span>
###xml 619 625 <span type="species:ncbi:13443">coffee</span>
The findings have been in part dependent on the type of study: case-control studies have generally reported higher effect estimates than cohort studies [1]. In studies published more recently, the discrepancy between cohort and case-control studies persists [28]-[30]. As an explanation for the discrepancy between study types it has been suggested that coffee drinking has mainly acute or short-term effects, which cohort studies with extended follow-up periods would be likely to miss [27]. In general, the inconsistency between studies has been attributed to differences in coffee brews, study populations, range of coffee intake, confounding by smoking or other lifestyle factors, and measurement inaccuracy.
###end p 35
###begin p 36
###xml 97 100 97 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Happonen1">[7]</xref>
###xml 102 105 102 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Panagiotakos1">[9]</xref>
###xml 571 574 571 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Happonen1">[7]</xref>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Thelle1">[31]</xref>
###xml 60 66 <span type="species:ncbi:13443">coffee</span>
###xml 148 154 <span type="species:ncbi:13443">coffee</span>
###xml 534 540 <span type="species:ncbi:13443">coffee</span>
###xml 638 644 <span type="species:ncbi:13443">coffee</span>
###xml 754 760 <span type="species:ncbi:13443">coffee</span>
###xml 867 873 <span type="species:ncbi:13443">coffee</span>
Two recent studies have observed a U-shaped pattern between coffee consumption and CHD incidence [7], [9], suggesting that the relationship between coffee intake and CHD is more complex than previously recognized and offering yet another potential explanation for the contradictory findings in the literature. In both studies, the J- or U-shaped association persisted after adjustment for known risk factors for CHD, such as hypertension, high LDL cholesterol concentration, and diabetes, which could partially mediate the effects of coffee intake. In our previous study [7], the association was also independent of the brewing method of coffee, which has long been offered as a likely explanation for increased risk among heavy drinkers of non-filtered coffee [31]. In addition, the association was stronger during the first years of follow-up, which indicates that coffee intake is more relevant with respect to the acute rather than chronic processes related to coronary disease.
###end p 36
###begin p 37
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Cornelis1">[32]</xref>
###xml 203 209 <span type="species:ncbi:13443">coffee</span>
###xml 289 295 <span type="species:ncbi:13443">coffee</span>
Caffeine is metabolized by the polymorphic cytochrome P450 1A2 (CYP1A2) enzyme. Recently Cornelis and co-workers determined whether CYP1A2 genotype modifies the association between intake of caffeinated coffee and the risk of nonfatal myocardial infarction [32]. They found that intake of coffee was associated with an increased risk of myocardial infarction only among individuals with slow caffeine metabolism and suggested that caffeine plays a role in this association.
###end p 37
###begin p 38
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Robertson1">[10]</xref>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Smits1">[33]</xref>
###xml 852 856 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Lane1">[12]</xref>
###xml 1215 1219 1215 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Gidron1">[34]</xref>
###xml 1419 1423 1419 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Madsen1">[35]</xref>
###xml 1487 1491 1487 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Stevens1">[36]</xref>
###xml 99 105 <span type="species:ncbi:13443">coffee</span>
###xml 137 143 <span type="species:ncbi:13443">Coffee</span>
###xml 540 546 <span type="species:ncbi:13443">coffee</span>
These findings led us to consider novel explanations behind the dose-response relationship between coffee consumption and CHD incidence. Coffee and caffeine have been shown to stimulate adrenomedullary secretion, resulting in raised levels of circulating catecholamines, adrenaline in particular [10], [33]. In a subgroup of the present study population with urinary catecholamine excretion measured at baseline, we also observed a marked increase in adrenaline excretion and some increase in the excretion of noradrenaline with increasing coffee intake. Increases in circulating catecholamine levels and cortisol are characteristic of the response to stress, both psychological and physiological, and caffeine has been shown to potentiate stress-related increases in plasma adrenaline and cortisol concentrations, both in habitual and light consumers [12]. Stress in turn is a recognized risk factor for CHD. Furthermore, stress appears to be more strongly related to the rapid and more transient processes (such as rupture of atherosclerotic plaques with subsequent platelet activation, thrombus formation, and vasospasm) that lead to acute coronary syndromes rather than to the long-term atherosclerotic process [34]. On the other hand, treatment with beta-adrenoceptor blocking agents has been shown to effectively reduce the risk of acute coronary syndromes during acute periods of stress, such as surgical stress [35], which is characterized by elevated adrenaline and cAMP levels [36].
###end p 38
###begin p 39
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Eisenhofer1">[37]</xref>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Syvnen1">[38]</xref>
###xml 799 803 799 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Kumada1">[39]</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Saboury1">[40]</xref>
###xml 920 921 920 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 995 999 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Zhu1">[41]</xref>
###xml 64 70 <span type="species:ncbi:13443">coffee</span>
###xml 738 744 <span type="species:ncbi:13443">coffee</span>
###xml 1090 1096 <span type="species:ncbi:13443">coffee</span>
Hence, we hypothesized that heavy intake of caffeine-containing coffee induces a "chemical stress" and that the effect of this stress response on CHD incidence is more evident in those whose catecholamine metabolism is slower than usual and the mechanisms of tolerance may be overwhelmed. The main enzyme responsible for the metabolism of circulating catecholamines is COMT [37]. COMT activity shows functional polymorphism determined by the COMT gene: those who are homozygous for the low activity allele (about 25% of a Caucasian population) have only one-half to one-fourth of the enzyme activity of the other genetic variants [38]. These differences in COMT activity by genotype are likely to be more pronounced in heavy consumers of coffee, because caffeic acid directly inhibits COMT activity [39] and caffeine inhibits adenosine deaminase [40], resulting in a shift in homocysteine metabolism to the direction of S-adenosyl-homocysteine and consequent further inhibition of COMT activity [41]. Our finding of a 2.2 fold increase in the incidence of acute coronary events among heavy coffee drinkers in the low-activity COMT category, compared with the other two COMT categories, is highly compatible with this hypothesis.
###end p 39
###begin p 40
###xml 661 665 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000117-Brandin1">[42]</xref>
###xml 401 407 <span type="species:ncbi:13443">coffee</span>
###xml 590 593 <span type="species:ncbi:9606">men</span>
###xml 722 727 <span type="species:ncbi:9606">women</span>
Our study is limited by the small study cohort and the fact that only 78 CHD events were observed during an average follow-up of 13 years, resulting in imprecise effect estimates reflected as wide confidence intervals. Nevertheless, we were able to control for the most important potential confounding factors and still the difference in CHD incidence between the COMT activity categories among heavy coffee drinkers persisted. Residual confounding alone is unlikely to explain the remaining excess incidence. Another major limitation of our study is restriction of the study population to men only. Female hormones may influence catecholamine pharmacodynamics [42] and thus our findings are not necessarily applicable to women.
###end p 40
###begin p 41
###xml 106 112 <span type="species:ncbi:13443">coffee</span>
In conclusion, we suggest that circulating catecholamines play a role as mediators of the effect of heavy coffee intake on the risk of CHD events. The elevated risk may be more pronounced in or even restricted to those whose catecholamine metabolism is slower than usual. Further research is required to confirm or refute our hypothesis.
###end p 41
###begin p 42
We thank Drs. Jussi Kauhanen, Matti Karvonen, and Jari Tiihonen for the COMT genotype data, and the staff of the Research Institute of Public Health, University of Kuopio, for data management and laboratory measurements in the Kuopio Ischaemic Heart Disease Risk Factor Study.
###end p 42
###begin title 43
References
###end title 43
###begin article-title 44
###xml 19 25 <span type="species:ncbi:13443">coffee</span>
A meta-analysis of coffee, myocardial infarction, and coronary death.
###end article-title 44
###begin article-title 45
###xml 0 6 <span type="species:ncbi:13443">Coffee</span>
Coffee consumption and risk of ischaemic heart disease-a settled issue?
###end article-title 45
###begin article-title 46
###xml 23 28 <span type="species:ncbi:9606">human</span>
Effects of caffeine on human health.
###end article-title 46
###begin article-title 47
###xml 47 53 <span type="species:ncbi:13443">coffee</span>
Reproducibility of the serum lipid response to coffee oil in healthy volunteers.
###end article-title 47
###begin article-title 48
###xml 27 33 <span type="species:ncbi:13443">coffee</span>
###xml 98 104 <span type="species:ncbi:9606">humans</span>
Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans.
###end article-title 48
###begin article-title 49
###xml 0 6 <span type="species:ncbi:13443">Coffee</span>
Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking.
###end article-title 49
###begin article-title 50
###xml 0 6 <span type="species:ncbi:13443">Coffee</span>
###xml 96 99 <span type="species:ncbi:9606">men</span>
Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men.
###end article-title 50
###begin article-title 51
###xml 0 6 <span type="species:ncbi:13443">Coffee</span>
Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality.
###end article-title 51
###begin article-title 52
###xml 23 29 <span type="species:ncbi:13443">coffee</span>
The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case-control study.
###end article-title 52
###begin article-title 53
Effects of caffeine on plasma renin activity, catecholamines and blood pressure.
###end article-title 53
###begin article-title 54
###xml 64 67 <span type="species:ncbi:9606">man</span>
Tolerance to the humoral and hemodynamic effects of caffeine in man.
###end article-title 54
###begin article-title 55
Caffeine effects on cardiovascular and neuroendocrine responses to acute psychosocial stress and their relationship to level of habitual caffeine consumption.
###end article-title 55
###begin article-title 56
###xml 26 32 <span type="species:ncbi:13443">coffee</span>
Cardiovascular effects of coffee and caffeine.
###end article-title 56
###begin article-title 57
Effect of behavior state on caffeine's ability to alter blood pressure.
###end article-title 57
###begin article-title 58
Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study.
###end article-title 58
###begin article-title 59
###xml 100 103 <span type="species:ncbi:9606">men</span>
High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men.
###end article-title 59
###begin article-title 60
###xml 130 133 <span type="species:ncbi:9606">men</span>
Nutrition data collection in the Kuopio Ischaemic Heart Disease Risk Factor Study: Nutrient intake of middle-aged Eastern Finnish men.
###end article-title 60
###begin article-title 61
Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction.
###end article-title 61
###begin article-title 62
###xml 85 88 <span type="species:ncbi:9606">men</span>
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
###end article-title 62
###begin article-title 63
###xml 88 91 <span type="species:ncbi:9606">men</span>
Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland.
###end article-title 63
###begin article-title 64
Blood pressure, dietary fats, and antioxidants.
###end article-title 64
###begin article-title 65
Acute myocardial infarction (AMI) in Finland-baseline data from the FINMONICA AMI register in 1983-1985.
###end article-title 65
###begin article-title 66
###xml 3 9 <span type="species:ncbi:13443">coffee</span>
Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham study.
###end article-title 66
###begin article-title 67
###xml 0 6 <span type="species:ncbi:13443">Coffee</span>
###xml 48 51 <span type="species:ncbi:9606">men</span>
Coffee, caffeine, and cardiovascular disease in men.
###end article-title 67
###begin article-title 68
###xml 0 6 <span type="species:ncbi:13443">Coffee</span>
###xml 49 54 <span type="species:ncbi:9606">women</span>
Coffee consumption and coronary heart disease in women. A ten-year follow-up.
###end article-title 68
###begin article-title 69
###xml 0 6 <span type="species:ncbi:13443">Coffee</span>
###xml 54 57 <span type="species:ncbi:9606">men</span>
Coffee drinking and nonfatal myocardial infarction in men under 55 years of age.
###end article-title 69
###begin article-title 70
###xml 0 6 <span type="species:ncbi:13443">Coffee</span>
Coffee consumption and the incidence of coronary heart disease.
###end article-title 70
###begin article-title 71
###xml 0 6 <span type="species:ncbi:13443">Coffee</span>
Coffee consumption and the risk of coronary heart disease and death.
###end article-title 71
###begin article-title 72
###xml 18 24 <span type="species:ncbi:13443">coffee</span>
Alcohol, smoking, coffee and risk of non-fatal acute myocardial infarction in Italy.
###end article-title 72
###begin article-title 73
###xml 35 41 <span type="species:ncbi:13443">coffee</span>
Association of boiled and filtered coffee with incidence of first nonfatal myocardial infarction: the SHEEP and the VHEEP study.
###end article-title 73
###begin article-title 74
###xml 0 6 <span type="species:ncbi:13443">Coffee</span>
Coffee, tea and coronary heart disease.
###end article-title 74
###begin article-title 75
###xml 0 6 <span type="species:ncbi:13443">Coffee</span>
Coffee, CYP1A2 genotype, and risk of myocardial infarction.
###end article-title 75
###begin article-title 76
###xml 54 60 <span type="species:ncbi:13443">coffee</span>
The role of epinephrine in the circulatory effects of coffee.
###end article-title 76
###begin article-title 77
Molecular and cellular interface between behavior and acute coronary syndromes.
###end article-title 77
###begin article-title 78
Cyclic AMP, adrenaline and noradrenaline in plasma during surgery.
###end article-title 78
###begin article-title 79
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review.
###end article-title 79
###begin article-title 80
Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma.
###end article-title 80
###begin article-title 81
###xml 213 221 <span type="species:ncbi:9606">patients</span>
Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland.
###end article-title 81
###begin article-title 82
Dehydrodicaffeic acid dilactone, an inhibitor of catechol-O-methyl transferase.
###end article-title 82
###begin article-title 83
Inhibition study of adenosine deaminase by caffeine using spectroscopy and isothermal titration calorimetry.
###end article-title 83
###begin article-title 84
On the mechanism of homocysteine pathophysiology and pathogenesis: a unifying hypothesis.
###end article-title 84
###begin article-title 85
###xml 85 88 <span type="species:ncbi:10116">rat</span>
Oestrogen modulates vascular adrenergic reactivity of the spontaneously hypertensive rat.
###end article-title 85
###begin title 86
Figures and Tables
###end title 86
###begin p 87
###xml 44 47 <span type="species:ncbi:9606">men</span>
###xml 95 101 <span type="species:ncbi:13443">coffee</span>
Odds ratios of acute coronary events in 773 men initially free from CHD by joint categories of coffee intake and COMT genotype; predicted from a logistic model with age, smoking, family history of CHD, plasma vitamin C concentration, systolic blood pressure, serum HDL and LDL cholesterol concentration, and diabetes as covariates.
###end p 87
###begin title 88
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt101">*</xref>
###xml 29 41 <span type="species:ncbi:9606">participants</span>
###xml 91 97 <span type="species:ncbi:13443">coffee</span>
Characteristics of the study participants, according to their average daily consumption of coffee.*
###end title 88
###begin p 89
Plus-minus values are means+/-SD.
###end p 89
###begin p 90
Light, 1-375 mL; moderate, 376-813 mL; and heavy, more than 814 mL.
###end p 90
###begin title 91
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt104">*</xref>
###xml 29 41 <span type="species:ncbi:9606">participants</span>
Characteristics of the study participants, according to their COMT genotype.*
###end title 91
###begin p 92
Plus-minus values are means+/-SD.
###end p 92
###begin p 93
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HH</italic>
###xml 46 48 46 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LH</italic>
###xml 68 70 68 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LL</italic>
HH, homozygous for high COMT activity allele; LH, heterozygous; and LL, homozygous for low COMT activity allele.
###end p 93
###begin title 94
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt107">*</xref>
###xml 126 132 <span type="species:ncbi:13443">coffee</span>
Distribution of acute coronary events in the study population during an average follow-up of 13 years, according to the joint coffee intake-COMT genotype categories.*
###end title 94
###begin p 95
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HH</italic>
###xml 46 48 46 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LH</italic>
###xml 68 70 68 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LL</italic>
HH, homozygous for high COMT activity allele; LH, heterozygous; and LL, homozygous for low COMT activity allele.
###end p 95
###begin p 96
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 96
###begin p 97
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported in part by grants from the Academy of Finland (201688 and 80185 for S.V.), the Ministry of Education of Finland, the city of Kuopio, and the National Heart, Lung, and Blood Institute of the United States. Additional support was provided to P.H. by the Juho Vainio Foundation, the Finnish Cultural Fund/North Savo Fund, the Yrjo Jahnsson Foundation, and the Finnish Foundation for Medical Science.
###end p 97

